BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 17868209)

  • 1. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions associated with nefopam.
    Pillans PI; Woods DJ
    N Z Med J; 1995 Sep; 108(1008):382-4. PubMed ID: 7566787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions to anthelmintics.
    Bagheri H; Simiand E; Montastruc JL; Magnaval JF
    Ann Pharmacother; 2004 Mar; 38(3):383-8. PubMed ID: 14749518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does memantine induce bradycardia? A study in the French PharmacoVigilance Database.
    Gallini A; Sommet A; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):877-81. PubMed ID: 18500725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database.
    Fuzier R; Serres I; Guitton E; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2013 Jan; 36(1):55-62. PubMed ID: 23315296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug related falls: a study in the French Pharmacovigilance database.
    Souchet E; Lapeyre-Mestre M; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):11-6. PubMed ID: 15508129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costs.
    Noize P; Bénard-Laribière A; Aulois-Griot M; Moore N; Miremont-Salamé G; Haramburu F
    Am J Clin Dermatol; 2010; 11(2):131-6. PubMed ID: 20141234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
    Choquet-Kastylevsky G; Vial T; Santolaria N; Nageotte A; Faure M; Claudy A; Descotes J
    Ann Dermatol Venereol; 2001 Apr; 128(4):507-11. PubMed ID: 11395648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions to local anaesthetics: a review of the French pharmacovigilance database.
    Fuzier R; Lapeyre-Mestre M; Samii K; Montastruc JL;
    Drug Saf; 2009; 32(4):345-56. PubMed ID: 19388725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effects of locally applied drugs].
    Bagheri H; Frelezeau F; Montastruc JL
    Therapie; 2000; 55(1):211-9. PubMed ID: 10860026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.